BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2021
View Archived Issues
CEPI and VBI Vaccines partner to develop eVLP vaccine candidates against COVID-19 variants
Read More
Venatorx selects VNRX-9945 as clinical candidate against HBV
Read More
Enrollment opens in phase III trial of [177Lu]PNT-2002 for metastatic CRPC
Read More
First clinical results reported for SeVRSV vaccine in healthy adults
Read More
Moderna begins dosing with modified COVID-19 vaccines in amended phase II study
Read More
Nouscom cleared in Spain to begin phase Ib study of personalized cancer immunotherapy NOUS-PEV
Read More
First patients enrolled in phase I study of PTP-001 as treatment of knee OA
Read More
Positive biomarker data from phase II study of EB-613 in postmenopausal osteoporosis
Read More
Renibus initiates phase II trial of RBT-1 for prevention of AKI
Read More
BeiGene discloses MAP4K1 inhibitors
Read More
Sichuan Haisco Pharmaceutical synthesizes influenza virus hemagglutinin inhibitors
Read More
Hinova Pharmaceuticals identifies new thyroid hormone receptor beta agonists
Read More
Genfleet Therapeutics presents GTPase KRAS mutant inhibitors
Read More
BoYuan RunSheng Pharma patents CAR T cells for cancer
Read More
Novel antibody cocktail prevents SARS-CoV-2 viral escape mutations
Read More
Direct bladder vaccination halts recurrent UTIs
Read More
Tilavonemab does not show evidence of efficacy in phase II study in progressive supranuclear palsy
Read More
Sanofi and Translate Bio begin phase I/II study of MRT-5500 mRNA COVID-19 vaccine candidate
Read More
Takeda compound targets O-GlcNAcase for neurodegenerative disorders
Read More
SymBio submits IND for phase II trial of intravenous brincidofovir for pediatric AdV infections
Read More
Brilacidin inhibits SARS-CoV-2 in vitro
Read More
European Commission grants conditional marketing authorization for J&J COVID-19 vaccine
Read More
VX-880 enters phase I/II trial for type 1 diabetes
Read More